464280.KQ
Tdspharm
KOE · Healthcare · Drug Manufacturers - General · KR
KRW 5,820.00
−1.02%Margins
Gross margin
27.5%
EBITDA margin
19.5%
EBIT margin
17.1%
Net margin
15.7%
FCF margin
-18.3%
11.5%
Return on equity
8.1%
Return on assets
9.6%
Return on invested capital
0.52x
Asset turnover
KRW 6.5B
Cash from operations
KRW 5.2K
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026